Innovative Treatment Flyte's FDA-cleared, non-invasive system offers a first-line conservative solution for female urinary incontinence, positioning it as an attractive option for clinics and healthcare providers seeking effective and accessible pelvic health treatments.

Growing Financial Backing Recent seed funding rounds totaling over 10 million dollars, including investments from Boomerang Ventures and other investors, demonstrate strong market confidence and potential for expansion, creating opportunities to engage with investors and strategic partners.

Recent Product Launches The launch of the next-generation Flyte System with enhanced tracking and treatment capabilities signifies continuous innovation, opening avenues to collaborate with providers interested in the latest medical device advancements and improved patient outcomes.

Market Expansion Potential With a focused mission to transform pelvic health care and a relatively small but impactful team, there are significant opportunities to partner with healthcare providers and clinics looking for proven solutions in urinary incontinence management.

Digital Engagement The company's website utilizes advanced tracking and engagement tools such as Google Ads and Microsoft Clarity, indicating an active digital marketing strategy well-suited for outreach campaigns targeting medical professionals and pelvic health clinics.